Open Bug 1681056 Opened 2 days ago Updated 4 hours ago. Assertion failure: has Ion Script(), at jit/Jit Script.h:471 with GC
Empirical Formula (Hill Notation): C28H25N3O6S2. CAS Number: 1681056-61-0. Molecular Weight: 563.64. PubChem Substance ID: 329825506. Pricing and availability is not currently available.
Find 1681056-61-0 and related products for scientific research at MilliporeSigma
CAS#: 1681056-61-0 Description: OSMI-1 is an inhibitor of O-GlcNAc transferase (OGT). Chemical Structure OSMI-1. CAS# 1681056-61-0. Instruction. Theoretical Analysis
MW 563.64, Purity > 98%. Potent, cell-permeable, O-GlcNAc transferase (OGT) inhibitor. Inhibits protein O-GlcNAcylation in several mammalian cell lines without qualitatively altering cell surface N…
CAS No: 1681056-61-0 . Chemical Name: (R)-N-(Furan-2-ylmethyl)-2-(2-methoxyphenyl)-2-(2-oxo-1,2-dihydroquinoline-6-sulfonamido)-N-(thiophen-2-ylmethyl)acetamide. AOBIOUS launched this product in 2015. CITATIONS - Publications That Use AOBIOUS Product. 1) O-GlcNAcylation enhances the tumorigenic properties of cervical cancer cells in vitro
OSMI-1 is a cell permeable inhibitor of OGT (O-GlcNAc transferase). For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the K m factor for a mouse and then divide by the K m factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.
5. Discussion. The variability of BP during hemodialysis treatment, which is defined by either intradialytic hypotension or intradialytic hypertension, may be attributed in hemodynamic abnormalities or/and in a paradoxical response to the dialysis procedure in a subset of hemodialysis patients .
3 beds, 3 baths, 3552 sq. ft. house located at 9410 Canterbury St, Leawood, KS 66206. View sales history, tax history, home value estimates, and overhead views. APN HP56000000 0044.
OSMI-1 is an O-GlcNAc transferase (OGT) inhibitor with an IC50 value of 2.7 μM, it is cell permeable. OSMI-1 induces a mass shift of nucleoporin62 (Nup62) that corresponds to the loss of O-GlcNAc residues and decreases levels of cellular O-GlcNAcase